Axsome Therapeutics is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians. Read More
Sutter Health is a leading healthcare organization that provides high-quality, patient-centered care to communities in Northern California and other areas. With a network of hospitals, clinics, and physicians, Sutter’s divisions offer a wide range of services and specialties to meet the diverse needs of its patients. Sutter’s commitment to innovation and collaboration drives their success […] Read More
The Association of University Professors of Neurology (AUPN) was founded in 1967 and formally incorporated in 1968. It was organized originally to foster the development of academic neurology’s educational, research and patient care programs. The organization has always served as a forum for the Chairs of Departments or Divisions of Neurology in accredited medical schools […] Read More
Eisai Inc. is a human health care (hhc) company dedicated to pursuing innovative research and simplifying the treatment journey to help improve the lives of people affected by cancer, Alzheimer’s disease and other neurodegenerative conditions. Everything we do is guided by the simple principle that patients and their families come first, and we have a […] Read More
Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new […] Read More
argenx is a global immunology company committed to improving lives of people suffering from severe autoimmune diseases. The company developed and is commercializing the first approved neonatal Fc receptor blocker in the U.S., Japan, Israel, EU, UK, Canada and China and advancing its autoimmune pipeline across multiple serious autoimmune diseases. Read More
Wiley champions those who see knowledge as a force for good. A trusted leader in research and learning, our pioneering solutions and services are paving the way for knowledge seekers as they work to solve the world’s most important challenges. Around the globe, we break down barriers for innovators, empowering them to publish and advance […] Read More